Seraphim International

SERAPHIM INTERNATIONAL: Teamed with Universities around the world we have developed an industry first. We have invented/developed an AI autonomous robotic manufacturing, formulation, and personalized product system tied to an autonomous robotic logistics system that reduces production costs by 40% and formulation development by greater than 80%. It also reduces labor by greater than 90%, reduces inventory by greater than 35%, and  reduces floor space requirements by more than 70%.  We have greater than $70M in LOI's  in hand form the worlds largest cosmetics and Pharma companies  and we are market ready. Return on investment (ROI) will be nearly immediate with endless high return revenue streams. We present the possibility of multiple flips and/or a solid IPO. We are focused on the cosmetics industry but we can easily cross into drug developments, chemical formulations, supplement personalization and the cannabis markets. An investment in Seraphim will bring investors a diversified portfolio, a high yield ROI, a recession-proof technology platform, and a chance to participate actively as a team member or board member. We have self-invested to $3.5m to date, so  you can see that we have significant skin in the game so success is mission critical.  Our goal is to set up the first co-pack and production facility to pull in significant revenue and then build sister facilities globally. (Investment risk can also be leveraged against assets (machinery) and real estate.)  We would be live and turning revenue in 60-90 days after funding.   Our revenue streams include but are not limited to product formulation, personalized meds, supplements, cosmetics, etc., short run production, full run production, logistics, white label product development, and the development of our own products in stem cells, exosomes, and peptides.  Seraphim will produce long range opportunities, high returns, multiple-exits, IPO's, and much more.  Investors will become part of the team, know the tech inside and out, retain board seats, and get a significant percentage for their investment.  We get first in line opportunities for more than 30 universities globally so we will never be without a cutting-edge pipeline.  Our team members are mostly semi-retired C-Level Pharma folks, MD's, University Professors, and Financial Analysts. The heavy lifting on the technology is already done after 7 years of pure R&D and product development. This includes software, SAS, IOT, AI, and Apps. We have Fortune-500 partners globally already on-boarded that will allow us to hit the ground running.  And after 8 successful startup flips  with investor returns that were astronomical...  Seraphim is ready for the next successes story.  Finally... We have demonstrated (POP) Proof of Principal to our global customer network, we have a $40M marketing partner on-board, we have several world renowned doctors on our team,  a big law M&A corporate councel, a 20 year Baylor Health CFO, and significant scientists with IP. Our unique technologies/strategy is supported by our robust capabilities which allows us to focus, identify, and align markets with our technologies with long-term fundamental demand drivers that produce excellent market opportunities and exponential returns. We have a business plan, financials, etc.  Our ask/give is 7.5% of the company for each $1M invested as a reward for the support.  We have a pitch deck with videos upon request.